Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Future of PDSG?

Apparently not:

PDSG

"Revenue consisting of software licenses and associated services relating to PDSG’s CDX product decreased from approximately $568,000 for the fiscal year ended May 31, 2010 to approximately $469,000 for the fiscal year ended May 31, 2011. The decrease of approximately $99,000 was primarily due to the fact that revenue agreements are one time contracts that vary in size and scope depending upon the requirements of the customer."

Share
New Message
Please login to post a reply